TCG Crossover Management, LLC - ELEVATION ONCOLOGY INC ownership

ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 28 filers reported holding ELEVATION ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
TCG Crossover Management, LLC ownership history of ELEVATION ONCOLOGY INC
ValueSharesWeighting
Q4 2022$273,971
-56.3%
288,390
-48.0%
0.05%
-74.5%
Q3 2022$627,000
-19.3%
555,0000.0%0.19%
-43.0%
Q2 2022$777,000
-44.5%
555,0000.0%0.33%
-41.3%
Q1 2022$1,399,000
-58.1%
555,0000.0%0.56%
-64.1%
Q4 2021$3,341,000555,0001.56%
Other shareholders
ELEVATION ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 2,834,910$7,654,2573.31%
venBio Partners LLC 2,434,255$6,572,4892.84%
Velan Capital Investment Management LP 597,299$1,612,7070.92%
Exome Asset Management LLC 369,322$997,1700.87%
Logos Global Management LP 3,850,000$10,395,0000.84%
TANG CAPITAL MANAGEMENT LLC 3,060,000$8,262,0000.84%
Palo Alto Investors LP 1,800,106$4,860,2860.56%
Darwin Global Management, Ltd. 1,916,290$4,809,8880.56%
Ghost Tree Capital, LLC 600,000$1,620,0000.51%
Affinity Asset Advisors, LLC 1,468,825$3,965,8280.46%
View complete list of ELEVATION ONCOLOGY INC shareholders